A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

Validated biomarkers are needed to improve risk assessment and treatment decision-making for women with ductal carcinoma in situ (DCIS) of the breast. The Oncotype DX(®) DCIS Score (DS) was shown to predict the risk of local recurrence (LR) in individuals with low-risk DCIS treated by breast-conserv...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Breast Cancer Res Treat
Hlavní autoři: Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Robertson, Susan J., Slodkowska, Elzbieta, Fong, Cindy, Anderson, Joseph M., Jamshidian, Farid, Miller, Dave P., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2015
Témata:
Clinical Trial
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491104/
https://ncbi.nlm.nih.gov/pubmed/26119102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3464-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky